(VIANEWS) – MONTEA (MONT.BR), SARTORIUS STED BIO (DIM.PA), SPIE (SPIE.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MONTEA (MONT.BR)
13.9% sales growth and 8.42% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specializes in logistics real estate in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 31/12/2023 the property portfolio represented a total surface of 1,959,242 m², spread across 95 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €6.45.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 12.5. Meaning, the purchaser of the share is investing €12.5 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.42%.
Yearly Top and Bottom Value
MONTEA’s stock is valued at €80.60 at 17:20 EST, below its 52-week high of €88.20 and way higher than its 52-week low of €61.90.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 130.52M for the twelve trailing months.
More news about MONTEA.
2. SARTORIUS STED BIO (DIM.PA)
12.2% sales growth and 8.15% return on equity
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 10.9% and positive 44.7% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 2, 2024, the estimated forward annual dividend rate is 0.69 and the estimated forward annual dividend yield is 0.33%.
More news about SARTORIUS STED BIO.
3. SPIE (SPIE.PA)
7.3% sales growth and 12.36% return on equity
SPIE SA provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides building modelling and design services; IT maintenance and managed services; information and communications technology engineering and consulting services; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients, as well as in the areas of electrical and security, HVAC, and information and communications technology; and electrical, mechanical, and HVAC engineering services. The company also offers building information modelling, building management systems, augmented reality, IoT and data management, and smart maintenance services; oil and gas services; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, and tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the analysis of site conditions; planning, installation, and commissioning of technology; mechanical and industrial robotic solutions; and provision of electric solutions comprising lighting, street lighting, safety and security, prefabrication, and signage solutions. SPIE SA was founded in 1900 and is headquartered in Cergy-Pontoise, France.
Earnings Per Share
As for profitability, SPIE has a trailing twelve months EPS of €1.44.
PE Ratio
SPIE has a trailing twelve months price to earnings ratio of 24.18. Meaning, the purchaser of the share is investing €24.18 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.36%.
Volume
Today’s last reported volume for SPIE is 186455 which is 11.89% below its average volume of 211627.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 8.81B for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 14, 2024, the estimated forward annual dividend rate is 0.83 and the estimated forward annual dividend yield is 2.43%.
More news about SPIE.
4. SCANA (SCANA.OL)
6.9% sales growth and 13.34% return on equity
Scana ASA engages in the offshore, energy, and maritime businesses in Norway, rest of European countries, America, Asia, Africa, and Oceania. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, aquaculture, oil and gas, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. Scana ASA was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. The company was founded in 1646 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SCANA has a trailing twelve months EPS of kr0.15.
PE Ratio
SCANA has a trailing twelve months price to earnings ratio of 13.67. Meaning, the purchaser of the share is investing kr13.67 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.34%.
Sales Growth
SCANA’s sales growth is 5.9% for the current quarter and 6.9% for the next.
Moving Average
SCANA’s worth is below its 50-day moving average of kr2.22 and under its 200-day moving average of kr2.19.
Volume
Today’s last reported volume for SCANA is 1063870 which is 4.94% below its average volume of 1119170.
More news about SCANA.
5. VERALLIA (VRLA.PA)
6% sales growth and 46.92% return on equity
Verallia Société Anonyme manufactures and sells glass packaging products for beverages and food products worldwide. It provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.01.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.99. Meaning, the purchaser of the share is investing €8.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.92%.
More news about VERALLIA.
6. AXACTOR (ACR.OL)
5.2% sales growth and 9.72% return on equity
Axactor ASA, through its subsidiaries, operates as a debt management and collection company in Sweden, Finland, Germany, Italy, Norway, and Spain. It operates through two segments: Non-performing Loans and Third-Party Collection. The Non-performing Loans segment invests in portfolios of non-performing loans collected through amicable or legal proceedings. The Third-Party Collection segment provides debt collection services on behalf of third-party clients, which applies amicable and legal proceedings to collect the non-performing loans. This segment is also involved in helping creditors to prepare documentation for future legal proceedings against debtors; and handling of invoices between the invoice date and the default date and sending out reminders. Axactor ASA was incorporated in 1982 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, AXACTOR has a trailing twelve months EPS of kr1.3.
PE Ratio
AXACTOR has a trailing twelve months price to earnings ratio of 3.75. Meaning, the purchaser of the share is investing kr3.75 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.72%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AXACTOR’s EBITDA is 989.79.
More news about AXACTOR.
